Correlation Between HLS Therapeutics and Biosyent

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HLS Therapeutics and Biosyent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HLS Therapeutics and Biosyent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HLS Therapeutics and Biosyent, you can compare the effects of market volatilities on HLS Therapeutics and Biosyent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HLS Therapeutics with a short position of Biosyent. Check out your portfolio center. Please also check ongoing floating volatility patterns of HLS Therapeutics and Biosyent.

Diversification Opportunities for HLS Therapeutics and Biosyent

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between HLS and Biosyent is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding HLS Therapeutics and Biosyent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biosyent and HLS Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HLS Therapeutics are associated (or correlated) with Biosyent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biosyent has no effect on the direction of HLS Therapeutics i.e., HLS Therapeutics and Biosyent go up and down completely randomly.

Pair Corralation between HLS Therapeutics and Biosyent

Assuming the 90 days trading horizon HLS Therapeutics is expected to generate 1.13 times more return on investment than Biosyent. However, HLS Therapeutics is 1.13 times more volatile than Biosyent. It trades about 0.16 of its potential returns per unit of risk. Biosyent is currently generating about 0.12 per unit of risk. If you would invest  417.00  in HLS Therapeutics on April 24, 2025 and sell it today you would earn a total of  74.00  from holding HLS Therapeutics or generate 17.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

HLS Therapeutics  vs.  Biosyent

 Performance 
       Timeline  
HLS Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in HLS Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, HLS Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Biosyent 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Biosyent are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Biosyent may actually be approaching a critical reversion point that can send shares even higher in August 2025.

HLS Therapeutics and Biosyent Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HLS Therapeutics and Biosyent

The main advantage of trading using opposite HLS Therapeutics and Biosyent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HLS Therapeutics position performs unexpectedly, Biosyent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biosyent will offset losses from the drop in Biosyent's long position.
The idea behind HLS Therapeutics and Biosyent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas